SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 14.53 |
Enterprise Value ($M) | 8.72 |
Book Value ($M) | 16.33 |
Book Value / Share | 0.96 |
Price / Book | 0.89 |
NCAV ($M) | 7.51 |
NCAV / Share | 0.44 |
Price / NCAV | 1.93 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.63 |
Return on Assets (ROA) | -0.80 |
Return on Equity (ROE) | -1.36 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.97 |
Current Ratio | 5.97 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 19.95 |
Assets | 28.77 |
Liabilities | 12.44 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.65 |
Operating Income | -16.89 |
Net Income | -18.40 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -17.49 |
Cash from Investing | -0.53 |
Cash from Financing | 3.47 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 4.99 | 3.01 | |
13G/A | Lind Global Fund II LP | 4.20 | ||
13D | Nantahala Capital Management, LLC | 11.80 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
3,033 | 7,125 | 42.57 | |
1,168 | 10,422 | 11.21 | |
15,911 | 31,060 | 51.23 | |
15,366 | 72,146 | 21.30 | |
4,751 | 30,177 | 15.74 | |
(click for more detail) |
Similar Companies | |
---|---|
TCRX – TScan Therapeutics, Inc. | TENK – TenX Keane Acquisition |
TKNO – Alpha Teknova, Inc. | TNGX – Tango Therapeutics, Inc. |
TRDA – Entrada Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io